AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE MEDICAL MARIJUANA ACT.
Do you support it?
Want to know if it passes?
We'll email you when HB 141 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HB 141.
You're tracking HB 141
We'll email you the moment it moves.
HB 141 — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE MEDICAL MARIJUANA ACT.
Last action — Signed by Governor
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
✓Passed House
-
✓Passed Senate
-
✓To Executive
-
6Enacted
This bill has been enacted into law. Introduced May 06, 2019. Enacted.
Prognosis
Where this bill stands today.
Odds of enactment
HighHow often bills like it became law.
-
Enacted
Current position in the legislative process.
-
20 sponsors
4 primary, 16 co-sponsors signed on.
-
Bipartisan support
Sponsored across 2 parties (7 D · 4 R) — cross-party backing.
-
Cleared a recorded vote
Passed 2 recorded votes so far.
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
Summary
New daily persistent headache (NDPH) is a rare headache disorder characterized by daily and unremitting headaches that can last up to 3 days. Headache onset is abrupt and the throbbing, pressure-like pain is usually on both sides of the head. In order to be diagnosed with this syndrome, a patient has chronic daily headaches that are present more than 15 days a month for more than 3 months. The age of onset ranges from 6 to greater than 70 years old. It is found to be more common in females in both the adult and pediatric populations. Currently, there is no specific treatment for NDPH. Instead, most are treated similarly to migraines with prescriptions to opiates or narcotics such as gabapentin. In order to avoid the development of medication overuse or addiction, however, physicians do not advise patients to use pain relievers for more than 9 days a month even though the pain persists for many days more than that. Moreover, NDPH is an intractable headache disorder that is unresponsive to standard headache therapies. This bill adds new daily persistent headache and chronic debilitating migraines to the list of chronic or debilitating medical conditions for which a child under 18 may qualify as a patient to receive marijuana oil upon certification by a physician in accordance with the terms of the Delaware Medical Marijuana Act. This bill also adds new daily persistent headache to the list of chronic or debilitating medical conditions that qualifies an adult to be eligible for the use of medical marijuana.
Bill Text
What changed in the latest version
11 added · 64 removed11 line(s) added, 64 removed.
Minor-Brown &HOUSE Rep.OF REPRESENTATIVES 150th GENERAL ASSEMBLY HOUSE AMENDMENT NO.
Schwartzkopf1 &TO Sen.HOUSE BILL NO.
McBride141 &AMEND Sen.House Bill No.
Lopez141 Reps.by deleting line 35 in its entirety and inserting in lieu thereof the following:
Baumbach,“severe, Bolden,painful Brady,and Carson,persistent Chukwuocha,muscle Griffith,spasms; Jaques, K.
Johnson,chronic Kowalko,debilitating Postles,migraines Ramone,and Seigfried,new D.daily persistent headache that are refractory to conventional treatment and interventions;
Short,or” Shupe,SYNOPSIS Spiegelman,This K.amendment clarifies that in order for a child under the age of 18 who has chronic debilitating migraines and new daily persistent headache to qualify as a patient to receive marijuana oil upon certification by a physician, the headaches must be resistant to conventional treatment and interventions.
Williams HOUSE OF REPRESENTATIVES 150th GENERAL ASSEMBLY HOUSE BILL NO.
141 AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE MEDICAL MARIJUANA ACT.
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF DELAWARE:
Section 1.
Amend Chapter 49A, Title 16 of the Delaware Code by making deletions as shown by strikethrough and insertions as shown by underline as follows:
§ 4902A Definitions.
In this chapter, unless the context otherwise requires, the following definitions shall apply:
(3) "Debilitating medical condition'' means 1 or more of the following:
a. Terminal illness, cancer, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, decompensated cirrhosis, amyotrophic lateral sclerosis, agitation of Alzheimer's disease, post-traumatic stress disorder, intractable epilepsy, seizure disorder, glaucoma, chronic debilitating migraines, new daily persistent headache, or the treatment of these conditions.
b. A chronic or debilitating disease or medical condition or its treatment that produces 1 or more of the following:
cachexia or wasting syndrome;
severe, debilitating pain that has not responded to previously prescribed medication or surgical measures for more than 3 months or for which other treatment options produced serious side effects;
intractable nausea;
seizures;
severe and persistent muscle spasms, including those characteristic of multiple sclerosis.
c. Any other medical condition or its treatment added by the Department, as provided for in § 4906A of this title.
§ 4909A Issuance of registry identification cards.
(a) Except as provided in subsection (b) of this section, the Department shall:
(1) Verify the information contained in an application or renewal submitted pursuant to this chapter, and shall approve or deny an application or renewal within 45 days of receiving a completed application or renewal application.
MAWTEH Page 1 of 21 Released:
05/06/201905/16/2019 02:3712:32 PM (2) Issue1031500143 registry identification cards to a qualifying patient and his or her designated caregiver, if any, within 30 days of approving the application or renewal.
A designated caregiver must have a registry identification card for each of his or her qualifying patients.
(3) Enter the registry identification number of the registered compassion center the patient designates into the verification system.
(b) The Department shall not issue a registry identification card to a qualifying patient who is younger than 18 years of age, except as follows:
(1) The qualifying patient has any of the following related to a terminal illness:
a. Pain;
b. Anxiety;
c. Depression;
(2) The qualifying patient has intractable epilepsy or seizure disorder;
(3) The qualifying patient has a chronic or debilitating disease or medical condition where the patient has failed treatment involving 1 or more of the following symptoms:
cachexia or wasting syndrome;
intractable nausea;
severe, painful and persistent muscle spasms;
Show all 60 changed lines (20 more)
chronic debilitating migraines;
new daily persistent headache;
or (4) Any other medical condition or its treatment added by the Department, as provided for in § 4906A of this title.
(c) A qualifying patient who is younger than 18 years of age may only receive marijuana oil.
Section 2.
This Act shall be known as “Mia’s Law.” SYNOPSIS New daily persistent headache (NDPH) is a rare headache disorder characterized by daily and unremitting headaches that can last up to 3 days.
Headache onset is abrupt and the throbbing, pressure-like pain is usually on both sides of the head.
In order to be diagnosed with this syndrome, a patient has chronic daily headaches that are present more than days a month for more than 3 months.
The age of onset ranges from 6 to greater than 70 years old.
It is found to be more common in females in both the adult and pediatric populations.
Currently, there is no specific treatment for NDPH.
Instead, most are treated similarly to migraines with prescriptions to opiates or narcotics such as gabapentin.
In order to avoid the development of medication overuse or addiction, however, physicians do not advise patients to use pain relievers for more than 9 days a month even though the pain persists for many days more than that.
Moreover, NDPH is an intractable headache disorder that is unresponsive to standard headache therapies.
This bill adds new daily persistent headache and chronic debilitating migraines to the list of chronic or debilitating medical conditions for which a child under 18 may qualify as a patient to receive marijuana oil upon certification by a physician in accordance with the terms of the Delaware Medical Marijuana Act.
This bill also adds new daily persistent headache to the list of chronic or debilitating medical conditions that qualifies an adult to be eligible for the use of medical marijuana.
HD :
NSW :
MAW Page 2 of 2 Released:
05/06/2019 02:37 PM 2141500100
Show all 60 changed rows (20 more)
Action History
-
Signed by Governor
-
Passed By Senate. Votes: 20 YES 1 ABSENT
-
Reported Out of Committee (Health & Social Services) in Senate with 2 Favorable, 3 On Its Merits
-
Passed By House. Votes: 41 YES
-
Amendment HA 1 to HB 141 - Passed In House by Voice Vote
-
Amendment HA 1 to HB 141 - Introduced and Placed With Bill
-
Reported Out of Committee (Health & Human Development) in House with 3 Favorable, 4 On Its Merits
-
Introduced and Assigned to Health & Human Development Committee in House
Sponsors
- Kimberly Williams · Cosponsor
- Bryan W. Shupe · Cosponsor
- Daniel B. Short · Cosponsor
- Charles S Postles Jr. · Cosponsor
- Kendra Johnson · Cosponsor
- Krista Griffith · Cosponsor
- Nnamdi O. Chukwuocha · Cosponsor
- William J. Carson · Cosponsor
- Stephanie T. Bolden · Cosponsor
- Melissa Minor-Brown · Primary
- Jeffrey N. Spiegelman · Cosponsor
- David B. McBride · Primary
- Ernesto B Lopez · Primary
- Peter C. Schwartzkopf · Primary
- Paul S. Baumbach · Cosponsor
- Gerald L. Brady · Cosponsor
- Earl G. Jaques Jr. · Cosponsor
- John A. Kowalko · Cosponsor
- Michael Ramone · Cosponsor
- Raymond Seigfried · Cosponsor
Sponsorship breakdown
Export CSV (upgrade) →4 sponsors · 16 co-sponsors · 42 not signed on
Sponsors (4)
Co-sponsors (16)
- Kimberly Williams Democratic
- Bryan W. Shupe Republican
- Daniel B. Short Republican
- Charles S Postles Jr. Republican
- Kendra Johnson Democratic
- Krista Griffith Democratic
- Nnamdi O. Chukwuocha Democratic
- William J. Carson Democratic
- Stephanie T. Bolden Democratic
- Jeffrey N. Spiegelman Republican
- Paul S. Baumbach
- Gerald L. Brady
- Earl G. Jaques Jr.
- John A. Kowalko
- Michael Ramone
- Raymond Seigfried
Not signed on (42)
42 members have not signed on to this bill.
Show all 42 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Votes
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 7 | 0 | 0 | 0 |
| Democratic | 8 | 0 | 0 | 1 |
| Republican | 5 | 0 | 0 | 0 |
| Total | 20 | 0 | 0 | 1 |
| % of votes cast | 95% | 0% | 0% | 5% |
How each member voted (21)
| Member | Party | Vote |
|---|---|---|
| Anthony Delcollo | — | Yea |
| Bruce C. Ennis | — | Yea |
| Catherine Cloutier | — | Yea |
| Colin Bonini | — | Yea |
| David B. McBride | — | Yea |
| Ernesto B Lopez | — | Yea |
| Harris B. McDowell | — | Yea |
| Bryan Townsend | Democratic | Yea |
| Darius J. Brown | Democratic | Not Voting |
| David P. Sokola | Democratic | Yea |
| John "Jack" Walsh | Democratic | Yea |
| Laura V. Sturgeon | Democratic | Yea |
| Nicole Poore | Democratic | Yea |
| S. Elizabeth Lockman | Democratic | Yea |
| Stephanie L. Hansen | Democratic | Yea |
| Trey Paradee | Democratic | Yea |
| Brian Pettyjohn | Republican | Yea |
| Bryant L. Richardson | Republican | Yea |
| Dave G. Lawson | Republican | Yea |
| David L. Wilson | Republican | Yea |
| Gerald W. Hocker | Republican | Yea |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 17 | 0 | 0 | 0 |
| Democratic | 12 | 0 | 0 | 0 |
| Republican | 12 | 0 | 0 | 0 |
| Total | 41 | 0 | 0 | 0 |
| % of votes cast | 100% | 0% | 0% | 0% |
How each member voted (41)
Subjects
Frequently asked questions
- What does HB 141 do?
- New daily persistent headache (NDPH) is a rare headache disorder characterized by daily and unremitting headaches that can last up to 3 days. Headache onset is abrupt and the throbbing, pressure-like pain is usually on both sides of the head. In order to be diagnosed with this syndrome, a patient has chronic daily headaches that are present more than 15 days a month for more than 3 months. The age of onset ranges from 6 to greater than 70 years old. It is found to be more common in females in both the adult and pediatric populations. Currently, there is no specific treatment for NDPH. Instead, most are treated similarly to migraines with prescriptions to opiates or narcotics such as gabapentin. In order to avoid the development of medication overuse or addiction, however, physicians do not advise patients to use pain relievers for more than 9 days a month even though the pain persists for many days more than that. Moreover, NDPH is an intractable headache disorder that is unresponsive to standard headache therapies. This bill adds new daily persistent headache and chronic debilitating migraines to the list of chronic or debilitating medical conditions for which a child under 18 may qualify as a patient to receive marijuana oil upon certification by a physician in accordance with the terms of the Delaware Medical Marijuana Act. This bill also adds new daily persistent headache to the list of chronic or debilitating medical conditions that qualifies an adult to be eligible for the use of medical marijuana.
- Who sponsors HB 141?
- HB 141 is sponsored by Kimberly Williams (Democratic), Bryan W. Shupe (Republican), Daniel B. Short (Republican), Charles S Postles Jr. (Republican), Kendra Johnson (Democratic), Krista Griffith (Democratic), Nnamdi O. Chukwuocha (Democratic), William J. Carson (Democratic), Stephanie T. Bolden (Democratic), Melissa Minor-Brown (Democratic), Jeffrey N. Spiegelman (Republican), David B. McBride, Ernesto B Lopez, Peter C. Schwartzkopf, Paul S. Baumbach, Gerald L. Brady, Earl G. Jaques Jr., John A. Kowalko, Michael Ramone, and Raymond Seigfried.
- What is the current status of HB 141?
- This bill has been enacted into law. Introduced May 06, 2019. Enacted.
- Where can I track HB 141?
- Track HB 141 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 141
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 141
Last checked for changes 2 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →